Allergic Bronchopulmonary Aspergillosis
📧 Sign up to get email alerts when something new happens for Allergic Bronchopulmonary Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Clinical trial evaluating real-world effectiveness of benralizumab for allergic bronchopulmonary aspergillosis and severe asthma; currently …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
This entry notes ongoing recruitment for a cohort study evaluating the efficacy and safety of biologic therapies in patients with allergic b…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome [NA]
This clinical trial is evaluating oral itraconazole alone versus itraconazole with systemic glucocorticoids in patients with Chronic Pulmona…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Immune Status and Disease Control of Inflammatory Airway Diseases
This clinical trial update describes a study evaluating immune status and disease control in inflammatory airway diseases, including COPD, a…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
A clinical trial is evaluating the efficacy and safety of bronchoscopic airway clearance with Amphotericin B spraying in patients with aller…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
A clinical trial is investigating the impact of environmental fungal exposure on asthma, allergic bronchopulmonary aspergillosis (ABPA), and…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC) [NA]
Completed clinical trial from University Hospital, Montpellier investigating bronchial epithelium modeling in severe asthma using human indu…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
This completed clinical trial investigated whether IgE directed against recombinant Aspergillus fumigatus antigens can aid in diagnosing all…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
A recruiting clinical study led by Qianfoshan Hospital aims to investigate the pathogenesis and inflammatory phenotype of Allergic Bronchopu…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine [Phase 2]
Phase 2 clinical trial evaluating Gallium-68-deferoxamine for imaging in pulmonary aspergillosis, including chronic pulmonary aspergillosis …
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Deflazacort Vs. Prednisolone in Acute-stage ABPA [Phase 2, Phase 3]
Clinical trial comparing deflazacort to prednisolone in acute-stage allergic bronchopulmonary aspergillosis, with Phase 2 and Phase 3 studie…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis [Phase 3]
Phase 3 randomized trial evaluating prednisolone, itraconazole, or their combination for Allergic Bronchopulmonary Aspergillosis; currently …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
ClinicalTrials.gov update on a voriconazole inhalation powder trial for pulmonary aspergillosis; the study is no longer available.
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
This entry reports a multicenter registration trial for allergic bronchopulmonary aspergillosis led by Peking University Third Hospital, cur…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) [Phase 2]
Phase 2 trial of dupilumab in Allergic bronchopulmonary aspergillosis (LIBERTY ABPA AIRED) has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Immune Profiles in CF Fungal Infection
A completed clinical trial update examining immune profiles in cystic fibrosis patients with fungal infections, including allergic bronchopu…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]
A randomized trial evaluated itraconazole in the acute phase of allergic bronchopulmonary aspergillosis (ABPA) across Phase 2 and Phase 3 st…
-
CLINICAL_TRIALS withdrawal · 2022-02-01Clinical Trial Update: Benralizumab in the Treatment of Patients With Severe Asthma With ABPA [Phase 4]
A Phase 4 trial evaluating benralizumab for severe asthma with ABPA has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects [Phase 1]
Phase 1 three-part study (single-ascending-dose, multiple-ascending-dose, and cross-over) of ZP-059 in healthy and asthmatic subjects; study…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). [Phase 2]
Phase 2 trial evaluating nebulised liposomal amphotericin B (Ambisome) as maintenance therapy for Allergic Bronchopulmonary Aspergillosis in…
-
CLINICAL_TRIALS research · 2018-08-23Clinical Trial Update: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating vitamin D for allergic bronchopulmonary aspergillosis complicating asthma has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Protocol TARC-ABPA [NA]
The ClinicalTrials.gov entry for Protocol TARC-ABPA studying allergic bronchopulmonary aspergillosis shows that the study status is complete…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis [NA]
This update notes the completion of an open-label vitamin D trial in patients with cystic fibrosis and allergic bronchopulmonary aspergillos…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing voriconazole to oral steroids for Allergic Bronchopulmonary Aspergillosis.
-
CLINICAL_TRIALS research · 2017-08-30Clinical Trial Update: Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
An update on a clinical study evaluating thymus and activation-regulated chemokine (TARC) as a diagnostic biomarker for allergic bronchopulm…